The rhodium (II) complexes Rh2(tfa)4.2(tfac) and Rh2(tfacam) 4 (tfacam CF3CONH-,tfa CF3COO-, tfac CF3CONH2) were synthesized and characterized b) microanalysis and electronic and vibrational spectroscopies. Rhz(tfacam)4 was tested both in vitro (U937 and K562 human leukemia cells and Ehrlich ascitic tumor cells) and in vivo for cytostatic activity and lethal dose determination, respectively. This is the first rhodium tetra-amidate to have its biological activity evaluated. The LDs0 value for Rh2(tfacam)4 is of the same order as that of cisplatin, and it was verified that the rhodium complex usually needs lower doses than cisplatin to promote the same inhibitory effects.
INTRODUCTION
In 1969, Rosenberg and coworkers studied the effect of electric fields on the growth of Escherichia coli and noted that platinum compounds of cis configuration showed cytostatic activity [1] . Today, platinic derivatives are widely used in tumor therapy, specially against testicular or ovarian carcinomas, and bladder, head and neck tumors [2] . The biological activity of cisplatin and other platinum derivatives has already been the scope of numerous reviews [3] . Following the pioneering work of Rosenberg, complexes of transition metals other than platinum such as titanium, ruthenium [2] , iridium [4] and rhodium have been and are still being tested for antitumor activity. The rhodium carboxylates, whose dimeric structure is shown in Figure ( R bridging ligand substituent group; L axial coordinating ligand which may be absent), are particularly noteworthy among the rhodium compounds.
The antitumor activity of rhodium complexes was first reported by Bear and coworkers [5] . Rhodium butyrate (R C3H7 in Figure 1 ) showed high in vitro cytostatic potential and in vivo antitumoral activity but with toxicity higher than that of cisplatin [2, 6, 7] . For this reason, this class of dinuclear complexes remains under study, and it is expected that structures may be found that ideally would have maximum antineoplasic effect with minimum or no toxic effect. Several dinuclear rhodium (II) complexes have been synthesized with this objective [8] .
The hopes regarding the chemotherapeutic potential of rhodium amidates ( Figure 2 ) are based on the pioneering work described by Bear [9] and on previous findings for platinum and prepared. U937 and K562 human leukemia cells were cultivated in RPMI-1640 medium and kept in tissue culture flasks at 37oC. Ehrlich ascitic cells were kept in Balb-c mice, sacrificed at the time of experiment, and from which mL of intraperitonial liquid was extracted. Inside a laminar flow cabinet, these cells were transferred to centrifuge tubes that were sealed and centrifuged at 1400 rpm for 5 minutes. The cell pellet was resuspended in a mixture of culture medium and PBS buffer solution. Cell counting was performed in Neubauer plates, working typically in the range of 3 to 4 x 105 cells/mL.
In the wells of tissue culture plates mL of cell solution, variable volumes of drug solutions and sufficient saline to equalize the dilutions were then added. The culture plates were incubated for 24 hours at 37oC with 5% CO2 atmosphere. Control cells received only saline.
After 24 hours, the content of each well was pipetted to Eppendorf flasks and centrifuged at 1500 rpm for 3 minutes. The supernatants were discarded and the pellet was resuspended in 500 mL of PBS and 500 mL of Trypan blue solution. A small volume of each flask was transferred to Neubauer plates and the living and dead cells were counted.
In vivo Biological Assays: After preliminary tests, a 2.5xl 0-3 M aqueous solution of Rh2 (tfacam)4 containing 5% w/w of TweenX-80 was prepared, in order to achieve adequate solubilization of the inorganic compound. This solution was prepared by dissolving 0.071 g (0.079 mmol) of Rhz(tfacam)4.2(tfac) in the minimum possible amount of an acetone-ethanol mixture (-10:1) in a 25 mL flask, forming a deep red solution characteristic of axial coordination with acetone. Then 1.25 g of TweenTM-80 was added, followed by manual homogeneization and elimination of the organic solvents through N 2 bubbling for to 1.5 hours. After evaporation, distilled water was carefully added to complete 25 mL. This final solution was purple.
Volumes of this solution ranging from 0.2 to 0.5 mL were injected intraperitoneally in groups of 10 to 11 male Balb-c mice (average weight: 22.5 g). The dead animals were counted after 6 days.
RESULTS AND DISCUSSION
Melting Reactiotr The yield of the reaction between Rh2(ac)4 and tfac was quantitative and the described method is reproducible. Drying of the amide proved to be important since traces of trifluoroacetic acid, the tfac hydrolysis product, could be involved in reduction processes of Rh(II) For the tetra-amidates there are four possible geometric isomers, according to the position of the NH groups. Generally, the isomer with Rh-N bonds in cis, as in Figure 2 , is preferentialy obtained (-94% [1 b,c]), a fact that led Bear and coworkers to suggest the restriction that "the nitrogen of the entering amidate ion cannot bind trans to any other nitrogen on the same rhodium atom" 11 d].
Electronic Spectroscopy: Table II [16] . Table III summarizes the relevant IR data for the free ligand tfac and some rhodium complexes. Table IV lists the main bands observed in the 100 to 500 cm-1 range. The Rh-Rh bond stretching frequency is practically independent of substitutions in the bridge ligands, but depends strongly on the nature and influence of the axial ligands. Its assignment has already been the subject of some controversy [cfr [17] [18] [19] [20] [21] . Using normal coordinate analysis, Pruchnik and coworkers [17] concluded that both of the reported bands (in the 170 180 and in the-280 300 cm-1 region) show a component of the Rh-Rh vibration, not as pure bands but instead coupled with Rh-Obridge vibrations, for example. (Table IV) to be mainly Rh-Rh in character. Conc.' (mol/kg) 2.2 x 10-5 3.4 x 10-5 4.5 x 10-5 5.6 x 10-5
Analysing the comparative data of IC50 we see that the rhodium drug usually requires half of the molar dose of cisplatin to achieve the same inhibitory effect. Nevertheless, with respect to K562 cells, both act in the same concentration ranges.
In vivo Biological Assays: Table VI shows the results of LD50 determinations employing male Balbc mice.
We obtained LDso of the rhodium complex as being 4.8 x 10-5 mol/kg (fidutial limits: 6.1 x 10-5 and 3.7 x 10-5 mol/kg). LDro, the lethal dose for 10% of the population, is a good first approach for tumor therapy tests. For Rh2(tfacam)4, its value is 2.4 x 10-5 mol/kg (fidutial limits: 3.7 x 10-5 and 1.5 x 10-5 mol/kg). In their review, Hydes and Russell [23a] 
